Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

Products & Services

Case study | Standardizing qPCR-based LDT prepa...

Products & Services

The hidden impact of residual DNA on microbial ...

VHH Antibodies: Current and emerging applications in therapy, diagnostics, and drug delivery

Previous post

COVID-19: Build your tactics to fight de pandemic

Next post

Recommended for you

VHH Antibodies: Current and emerging applic..

Products & Services

This article reviews current and emerging applications of VHH antibodies and discusses key trends shaping...
Continue Reading

Case study | Standardizing qPCR-based LDT p..

Products & Services

What if your LDTs were ready-to-use?
Discover how outsourcing the preparation of 35 in-house LDTs...
Continue Reading

The hidden impact of residual DNA on microb..

Products & Services

This article explores the hidden risks of residual bacterial DNA contamination in qPCR reagents and...
Continue Reading